ABSTRACT Serum-and-glucocorticoid-inducible-kinase-1 (SGK1) is under regulation of several hormones, mediators and cell stressors. More specifically, SGK1 expression is particularly sensitive to gluto hypertonicity, hyperglycemia, and ischemia. SGK1 is activated by insulin and growth factors via phosphatidylinositol-3-kinase, 3-phosphoinositide dependent-kinase PDK1, and mTOR. SGK1 up-regulates the Na + /K + -ATPase, a variety of carriers (e.g. NCC, NKCC, NHE1, NHE3, SGLT1, several amino acid transporters) and many ion channels (e.g. ENaC, SCN5A, TRPV4-6, Orai1/STIM1, ROMK, KCNE1/KCNQ1, GluR6, CFTR). SGK1 further up-regulates a number of sensitive functions contribute to regulation of epithelial transport, excitability, degranulation, matrix protein deposition, coagulation, platelet aggregation, migration, cell proliferation, and SGK1 knockout mice is mild. However, excessive SGK1 expression and activity participates in the pathophysiology of several disorders, including hypertension, obesity, diabetes, thrombosis, stroke, inflammation, autoimmune disease, fibrosis, and tumor growth. A SGK1 gene variant (prevalence ~3-5% prevalence in Caucasians, ~10% in Africans) predisposes to hypertension, -ing to SGK1-related diseases.
INTRODUCTION
The serum and glucocorticoid-inducible kinase 1 (SGK1) was cloned as a gene up-regulated by serum and glucocorticoids in rat mammary tumor cells. 1 Human SGK1 was identified as a gene up-regulated by cell shrinkage.
2 SGK1 is ubiquitously expressed.
2-5
Following stimulation of cell proliferation with serum, SGK1 may enter into the nucleus. 4 Following hyperosmotic shock or glucocorticoids stimulation, SGK1 is localized mainly in the cytosol.
1,4 SGK1 may further bind to the mitochondrial membrane. 2 The gene encoding human SGK1 is located in chromosome 6q23. 4 Several SGK1 variants have been identified differing in regulation of expression, subcellular localization and function. 2, 6 The present brief review discusses the function and pathophysiological significance of SGK1. In order to limit reference numbers, reviews are cited instead of earlier publications.
2,4,7-12

REGULATION OF SGK1 EXPRESSION AND ACTIVITY
SGK1 transcription is stimulated by hyperosmotic or isotonic cell shrinkage. 4 Accordingly, SGK1 expression is increased by dehydration 13 and a modest increase of extracellular salt concentration.
14 Intestinal SGK1 is up-regulated by saline ingestion.
15 SGK1 transcription is further stimulated by excessive glucose concentrations and diabetes, A6 and M1 cell swelling, mechanical stress, Ca 2+ chelation, metabolic acidosis, salt loading of spontaneously hypertensive mice, oxidative stress, heat shock, UV radiation, DNA damage, ischemia, neuronal injury, neuronal excitotoxicity, neuronal challenge by exposure to microgravity, fear conditioning, plus maze exposure, enrichment training, amphetamine, lysergic acid dimethylamide (LSD), electroconvulsive therapy, sleep deprivation, antidepressant fluoxetine, testicular torsion, high-salt diet of salt-sensitive rats as well as high-fat diet. , cyclic AMP, stress-activated protein kinase-2 (SAPK2, p38 kinase), protein kinase C, protein kinase Raf, big mitogen-activated protein kinase 1 (BMK1), extracellular signal-regulated kinase (ERK1/2), mitogen-activated protein kinase 14 (MAPK14), phosphatidylinositide-(PI)-3-kinase, reactive oxygen species, NADPH oxidases, nitric oxide, and EWS/NOR1(NR4A3) fusion protein.
2,4,39
SGK1 expression is further stimulated by transcriprion factor p53. 40 The SGK1 promoter binds receptors for glucocorticoids (GR), mineralocorticoids (MR), progesterone (PR), 1,25(OH)2D3 (VDR), retinoids (RXR), farnesoids (FXR), sterol regulatory element binding protein (SREBP), peroxysome proliferator activator binding protein (CREB), p53 tumor suppressor protein, Sp1 transcription factor, activating protein 1 (AP1), activating transcription factor 6 (ATF6), heat shock factor (HSF), reticuloendotheliosis vi--factors SMAD3 and SMAD4, and forkhead activin signal transducer (FAST).
1 The SGK1 promotor further harbors a tonicity-responsive enhancer (TonE) mediating suppression of SGK1 expression by the transcription factor TonE binding protein (TonEbP or NFAT5). SGK1 is activated by insulin, IGF1, hepatic growth factor (HGF), follicle stimulating hormone (FSH), thrombin, and corticosterone. 4, 42 The signalling involves phosphosphoinositide 3 kinase (PI3-kinase) and 3-phosphoinositide (PIP3)-dependent kinase PDK1.
2 Interaction of SGK1 and PDK1 is fostered by the scaffold protein Na + /H + exchanger regulating factor 2 (NHERF2). 4 PIP3 is degraded by the phosphatase and tensin homolog PTEN, which thus abrogates PDK1-dependent SGK1 activation.
4 SGK1 could further be stimulated by mammalian target of rapamycin mTOR complex-2 (mTORC2) and WNK1 (with no lysine kinase 1).
2,4,31,43-54 The SGK1 activating mTOR complex 2 (mTORC2) involves mTOR, Rictor (rapamycin-insensitive companion of mTOR), Sin1 (stress-activated protein kinaseinteracting protein 1), mLST8, and Protor-1.
48 SGK1 extracellular signal-regulated kinase 5 (BK/ERK5), cAMP, lithium, Ca
2+
-sensitive calmodulin-dependent protein kinase kinase (CaMKK), G-protein Rac1, neuronal depolarization, oxidation, hypertonicity, adhesion to fibronectin, and feeding.
2,4,55
SGK1 is ubiquitinated by Nedd4-2 (neuronal precursor cells expressed developmentally down-regulated) 4 and Rictor/Cullin-1, 56-58 which trigger SGK1 degradation. SGK1 ubiquitinylation and degradation are counteracted by glucocorticoid-induced leucine zipper protein-1.
59
SGK1-sensitive functions
The consensus sequence for phosphorylation by SGK1 is R-X-R-X-X-(S/T)-phi (X = any amino acid, R = arginine, phi = hydrophobic amino acid). 4 The only known specific SGK1 targets are N-myc down-regulated genes NDRG1 and NDRG2. 
SGK1-ASSOCIATED DISEASE
Hypertension
Owing to its stimulating effect on ENaC, SGK1 enhances renal tubular salt reabsorption.
2,9, 84, 130, [138] [139] [140] [141] Moreover, SGK1 enhances the salt appetite. The prevalence of the combination appears to be lower in Caucasians (3-5%) than in Africans (10%).
2,4 With regular diet blood pressure is similar in SGK1 knockout mice and their wild type littermates. 4 Treatment with a highfructose diet or a high-fat diet leading to hyperinsulinism, however, sensitizes blood pressure to high-salt intake in wild type mice but not in SGK1 knockout mice.
4,148 Activation of SGK1 by insulin presumably stimulates renal tubular salt reabsorption and may possibly foster renal salt retention and hypertension in type II diabetes.
2,4 SGK1 further contributes to glucocorticoid-induced hypertension.
2
Obesity
SGK1 stimulates the Na + coupled glucose transporter SGLT1 and thus accelerates intestinal glucose absorption. 4 Enhanced SGLT1 activity is in turn known to foster development of obesity, an effect presumably due to rapid increase of plasma glucose concentration with excessive insulin release and subsequent fat deposition.
2,4 SGK1 further stimulates adipocyte differentiation and adipogenesis. 149 Along those lines, body weight and prevalence of type 2 diabetes are enhanced in carriers of the I6CC/E8CC/CT SGK1 gene variant. 2 The hyperglycemia of diabetic individuals could stimulate intestinal SGK1 expression, followed by up-regulation of SGLT1 activity and further weight gain.
Hypercoagulability, thrombosis, and stroke
SGK1 stimulates coagulation by stimulating tissue factor expression 2 and increases the reagibility subsequent expression of the platelet Ca 2+ channel Orai1/STIM1. 65 Enhanced coagulation and platelet reagibility predispose to the occurrence of stroke 150 and thrombosis.
65
Inflammation and fibrosis SGK1 up-regulates pathogenic IL-23-dependent interleukin (IL)-17-producing CD4 + helper T cells (TH17 cells), 151 which play a decisive role in autoimmune disease. 151 The up-regulation of those cells by IL-23 requires SGK1, which is critical for the expression of the IL23 receptor.
14 SGK1 becomes effective by deactivation of Foxo1, a direct repressor of IL-23R expression.
14 TH17 cells are further up-regulated by modest increases of local NaCl concentrations, 14 which activates the p38/MAPK pathway again involving SGK1 and nuclear factor of activated T cells 5 (NFAT5, TONEBP). 151 Following NaCl exposure, TH17 cells up-regulate the pro-inflammatory cytokines a high-salt diet develop a particularly severe form of experimental autoimmune encephalomyelitis paralleled by enhanced infiltration of TH17 cells into the central nervous system. 151 4 a key stimulator of fibrosis. [152] [153] [154] [155] [156] [157] [158] factors Smad2/3. 159 SGK1 phosphorylates and thus inactivates Nedd4L, a ubiquitin ligase triggering the degradation of Smad2/3. 159 SGK1 expression is excessive in affected tissues of inflammatory and fibrosing diseases, such as lung fibrosis, diabetic nephropathy, glomerulonephritis, experimental nephrotic syndrome, obstructive nephropathy, liver scirrhosis, fibrosing pancreatitis, peritoneal fibrosis, Crohn's disease, and coeliac disease.
4,160-163 SGK1 fosters nuclear transconnective tissue growth factor (CTGF), 4 triggers prostaglandin formation, 164 modifies cell survival, [165] [166] [167] [168] and thus participates in the signalling of inflammation and fibrosis. [169] [170] [171] [172] Along those lines, SGK1 is required for the effect of excessive glucose concentrations on the formation of the matrix protein fibronectin. 173 Overexpression of SGK1 alone, however, does not appreciably up-regulate fibronectin formation, indicating that additional glucose-dependent mechanisms are required for the induction of fibrosis by hyperglycemia. 173 SGK1 is required for the up-regulation of CTGF formation and cardiac fibrosis following treatment of mice with the mineralocorticoid DOCA 4 and mineralocorticoid-induced aging of the skin.
31 SGK1 is involved in angiotensin II-induced cardiac CTGF formation and fibrosis 174, 175 and in cardiac remodelling following increased afterload. 109, 176, 177 Tumor growth Inhibition of SGK1 slows androgen-induced growth of prostate cancer cells.
2 SGK1 contributes to glucocorticoid-or colony-stimulating factor 1 (CSF1)-induced stimulation of invasiveness, motility, and adhesiveness.
4,10 Moreover, SGK1 counteracts the signalling of proapoptotic membrane androgen receptors [186] [187] [188] and regulates the membrane androgen receptor-induced signal transduction controlling actin cytoskeleton architecture and migration in colon tumor cells. SGK1 is up-regulated by ischemia and may be particularly important for survival of tumor cells during ischemia.
2,4,10,33 SGK1 may counteract energy depletion of tumor cells by stimulation of glucose uptake. 4 Moreover, SGK1-sensitive stimulation of the Na + /H + ion exchanger may lead to cytosolic alkalinization, 67 which enhances the glycolytic flux.
191
A positive correlation between SGK1 abundance and patient survival was paradoxically observed in adrenocortical carcinoma. 192, 193 Moreover, SGK1 abundance is reportedly down-regulated in several tumors, such as prostate cancer, ovarian tumors, hepatocellular carcinoma, and adenomatous polyposis coli (APC). 4, 10, 194 Development of those tumors thus appears to be independent from SGK1. Genetic SGK1 knockout, however, decreases the development of spontaneous tumors in APC deficient mice 2 and chemically induced colonic tumors in wild type mice. 195 It is tempting to speculate that high activity of PKB/Akt isoforms or SGK3 in tumor cells leads to down-regulation of SGK1 expression and decreases the requirement of SGK1 for tumor cell survival.
The mild phenotype of SGK1 knockout mice illustrates that, despite its multiple effects on cell proliferation and apoptosis, SGK1 is not critically important for cell proliferation and survival. 4 ,10 Thus, inhibition of SGK1 alone is presumably not sufficient to eliminate tumor cells. Nevertheless, particuarly in tumor cells with high SGK1 expression levels, SGK1 may contribute to the maintenance of tumor cell survival and resistance of tumor cells to ischema and therapy. contains three nuclear localization signals and regulates the epithelial Na+ channel (ENaC) at multiple levels.
